Patterns of use and potential impact of early beta-blocker therapy in non-ST-elevation myocardial infarctions with and without heart failure: Insights from the global registry of acute coronary events

被引：0
|
作者：
Emery, M [1 ]
Lopez-Sendon, J [1 ]
Steg, PG [1 ]
Anderson, FA [1 ]
Dabbous, OH [1 ]
Scheuble, A [1 ]
Eagle, KA [1 ]
机构：
[1] Univ Michigan, Hlth Syst, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：343A / 343A
页数：1
相关论文
共 47 条
  • [21] Has the ClOpidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT) of early β-blocker use in acute coronary syndromes impacted on clinical practice in Canada? Insights from the Global Registry of Acute Coronary Events (GRACE)
    Edwards, Jeremy
    Goodman, Shaun G.
    Yan, Raymond T.
    Welsh, Robert C.
    Kornder, Jan M.
    DeYoung, J. Paul
    Chauret, Denis
    Picard, Jean-Pierre
    Eagle, Kim A.
    Yan, Andrew T.
    AMERICAN HEART JOURNAL, 2011, 161 (02) : 291 - 297
  • [22] Management and Outcomes of Non-ST Elevation Acute Coronary Syndromes in Relation to Previous Use of Antianginal Therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE])
    Kang, Jaskaran S.
    Goodman, Shaun G.
    Yan, Raymond T.
    Lopez-Sendon, Jose
    Pesant, Yves
    Graham, John J.
    Fitchett, David
    Wong, Graham C.
    Rose, Barry F.
    Spencer, Frederick A.
    Yan, Andrew T.
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (01): : 51 - 56
  • [23] Previous beta-blocker therapy on admission for acute coronary syndrome is associated with decreased intra-hospital mortality and major cardiovascular events in patients without heart failure
    Khalil, C. Abi
    Alhabib, K.
    Singh, R.
    Asaad, N.
    Alfaleh, H.
    Alsheikh-Ali, A.
    Sulaiman, K.
    Hersi, A.
    Al Saif, S.
    Almahmeed, W.
    Al Suwaidi, J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 798 - 798
  • [24] The benefit of beta-blocker therapy in hospital survivors receiving primary percutaneous coronary intervention after ST-elevation myocardial infarction from the Korea Acute Myocardial Infarction Regis
    Lee, J. H.
    Jang, S. Y.
    Choi, W. S.
    Park, S. H.
    Yang, D. H.
    Park, H. S.
    Cho, Y.
    Chae, S. C.
    Jeong, M. H.
    Kim, Y. J.
    EUROPEAN HEART JOURNAL, 2012, 33 : 472 - 472
  • [25] Practice variation in reperfusion strategies for ST-segment elevation myocardial infarction: Early findings from the Global Registry of Acute Coronary Events (GRACE)
    Eagle, K
    EUROPEAN HEART JOURNAL, 2000, 21 : 527 - 527
  • [26] Contemporary Patterns of Early Coronary Angiography Use in Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry
    Hansen, Carolina Malta
    Wang, Tracy Y.
    Chen, Anita Y.
    Chiswell, Karen
    Bhatt, Deepak L.
    Enriquez, Jonathan R.
    Henry, Timothy
    Roe, Matthew T.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (04) : 369 - 380
  • [27] Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry)
    Abbott, J. Dawn
    Ahmed, Hanna N.
    Vlachos, Helen A.
    Selzer, Faith
    Williams, David O.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (02): : 190 - 195
  • [28] Low-molecular-weight heparin alone and with IIb/IIIa inhibitors in patients with renal failure and non-ST elevation acute coronary syndromes: Insights from the global registry of acute coronary events
    Collet, JP
    Agnelli, G
    Van de Werf, FJ
    Brieger, D
    Gurfinkel, EP
    Lopez-Sendon, J
    Gowda, N
    Montalescot, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 335A - 335A
  • [29] Use of Early Intravenous Beta Blockers in Patients with Acute ST-Segment Elevation Myocardial Infarction Without Heart Failure-Revival or Requiem?
    Latif, Azka
    Jia, Xiaoming
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (05) : 973 - 975
  • [30] Antitbrombotic and antiplatelet therapies in relation to risk stratification in patients with non-ST elevation acute coronary syndrome: insights from the Sino-Global Registry of Acute Coronary Events
    Zhang Li-jie
    Chen Yun-dai
    Song Xian-tao
    Zhao Fu-hai
    Lue Shu-zheng
    CHINESE MEDICAL JOURNAL, 2009, 122 (05) : 502 - 508
12345